Literature DB >> 2019177

The COPD Self-Efficacy Scale.

J K Wigal1, T L Creer, H Kotses.   

Abstract

Many individuals with COPD develop a lack of confidence regarding their ability to avoid breathing difficulty while participating in certain activities, however minimal the physical demands of the activity may be. This lack of confidence may be expressed as low self-efficacy. As a result of low self-efficacy, COPD patients may refrain from many routine activities of daily living. Identifying situations in which individuals with COPD experience low self-efficacy would allow the development of specific treatment interventions designed to increase the patient's self-efficacy in those situations and consequently increase activity. We developed a 34-item COPD Self-Efficacy Scale (CSES) to assess self-efficacy in individuals afflicted with COPD. The CSES has good test-retest reliability (r = .77), excellent internal consistency (Cronbach's alpha = .95), and a five-factor structure (negative affect, intense emotional arousal, physical exertion, weather/environmental, and behavioral risk factors.

Entities:  

Mesh:

Year:  1991        PMID: 2019177     DOI: 10.1378/chest.99.5.1193

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

1.  Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study.

Authors:  Gloria Y Yeh; David H Roberts; Peter M Wayne; Roger B Davis; Mary T Quilty; Russell S Phillips
Journal:  Respir Care       Date:  2010-11       Impact factor: 2.258

2.  Examining the efficacy of DVD technology compared to print-based material in COPD self-management education of rural patients.

Authors:  Michael Stellefson; Beth H Chaney; J Don Chaney
Journal:  Calif J Health Promot       Date:  2009-12

3.  Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Maher R Khdour; Ahmed F Hawwa; Joseph C Kidney; Bronagh M Smyth; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.953

4.  Domain-specific self-efficacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  Bradford E Jackson; David B Coultas; Jamile Ashmore; Rennie Russo; Jennifer Peoples; Minyong Uhm; Karan P Singh; Sejong Bae
Journal:  Ann Am Thorac Soc       Date:  2014-03

Review 5.  Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report.

Authors:  Kathleen W Wyrwich; Stephan D Fihn; William M Tierney; Kurt Kroenke; Ajit N Babu; Fredric D Wolinsky
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

Review 6.  Patient Education Provided by Physiotherapists for Patients with Chronic Obstructive Pulmonary Disease: Results of a Scoping Review.

Authors:  Judy King; Sarah Tessier; Marie-Josée Charette; Danica Gaudet
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

7.  The role of coping resources and coping style in quality of life of patients with asthma or COPD.

Authors:  A E Hesselink; B W J H Penninx; M A G Schlösser; H A H Wijnhoven; D A W M van der Windt; D M W Kriegsman; J Th M van Eijk
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

8.  The COPD Helplessness Index: a new tool to measure factors affecting patient self-management.

Authors:  Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Sara J Knight; Paul D Blanc; Mark D Eisner
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

Review 9.  Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations--a systematic review.

Authors:  Anja Frei; Anna Svarin; Claudia Steurer-Stey; Milo A Puhan
Journal:  Health Qual Life Outcomes       Date:  2009-09-26       Impact factor: 3.186

Review 10.  Activity monitoring in chronic obstructive pulmonary disease.

Authors:  Roberto Benzo
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 Nov-Dec       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.